dactinomycin has been researched along with nsc 354646 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Capranico, G; Jaxel, C; Kohn, KW; Markovits, J; Pommier, Y; Wassermann, K | 1 |
| Davis, FM; Mullins, TD; Newman, RA; Rose, KM; Wassermann, K | 1 |
2 other study(ies) available for dactinomycin and nsc 354646
| Article | Year |
|---|---|
Effects of morpholinyl doxorubicins, doxorubicin, and actinomycin D on mammalian DNA topoisomerases I and II.
Topics: Animals; Antibiotics, Antineoplastic; Camptothecin; Dactinomycin; DNA; DNA Damage; Doxorubicin; Mice; Structure-Activity Relationship; Topoisomerase I Inhibitors; Topoisomerase II Inhibitors | 1990 |
Selective inhibition of human ribosomal gene transcription by the morpholinyl anthracyclines cyanomorpholinyl- and morpholinyldoxorubicin.
Topics: Dactinomycin; Doxorubicin; Fluorescent Antibody Technique; HeLa Cells; Humans; Microscopy, Electron; Ribosomes; RNA Polymerase I; Transcription, Genetic | 1988 |